Skip to content

Global MDR and XDR TB control needs extra $2.15 billion by end of 2008, says WHO

Maraviroc approval delayed in the US

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

Hospital admissions involving people with HIV fall by 40% between 2000 and 2004 in US

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

HPV vaccinations recommended in UK for 12 and 13 year-old girls

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Antiretroviral therapy results bringing dilemmas for private sector

Million more AIDS deaths forecast in South Africa by 2010